DSDiara Raiane dos Santos

Diara Raiane dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diara Raiane dos Santos has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Three-dimensional analysis of the gait in patients with cervical myelopathy undergoing surgical treatment

    by Thabata Pasquini Soeira, Arielli de Souza Maximo, Emilly Zatta Pimenta, Diara Raiane dos Santos, Raphael de Rezende Pratali, Ricardo Lucca Cabarite Saheb, Carlos Fernando Pereira da Silva Herrero

    Observational, longitudinal, and prospective study. To describe gait characteristics and evaluate the impact of decompressive surgery on improving gait quality after surgical spine decompression in patients diagnosed with cervical spondylotic myelopathy (CSM). All participants underwent a three-dimensional gait assessment before the surgical procedure, three months, six months and one year of follow up. The outcome measures used were the "Gait Profile Score" (GPS) and the "Movement Analysis Profile" (MAP). The GPS and MAP variables of healthy individuals from a database were compared with the values obtained from our study patients. Ultimately, all variables were compared between the preoperative period and the postoperative evaluations. There was no difference in the GPS and MAP values in the postoperative period for the variables General Total, Ankle flexion and extension, Pelvis inclination, Hip abduction and adduction, Pelvis rotation and Foot progression. Compared to the preoperative time results, there was a difference in the Pelvis Obliquity GPS and MAP at 3 and 6 months. We also found differences in hip flexion and extension, knee flexion and extension, and hip rotation in the late postoperative period (one-year follow-up) compared to the preoperative period GPS and MAP results. In addition to characterizing the gait analysis in patients with CSM, this study demonstrated the gait changes in patients with CSM during the 1-year clinical follow-up after surgical treatment with decompression of the cervical spinal canal.

  • Open Access

    QUANTITATIVE AND QUALITATIVE INVESTIGATION OF THREE-DIMENSIONAL GAIT ANALYSIS IN PATIENTS WITH CERVICAL MYELOPATHY

    by Diara Raiane Santos, Emilly Zatta Pimenta, Thabata Pasquini Soeira, Felipe de Souza Serenza, Mariana Demétrio de Sousa Pontes, Carlos Fernando Pereira da Silva Herrero

    Objective: This study aims to describe a kinematic gait assessment protocol and identify its main alterations in individuals with cervical spondylotic myelopathy (CSM) compared to healthy patients. Methods: In total, 14 patients diagnosed with CSM were enrolled and submitted to a three-dimensional gait analysis. The movement of patients was captured with infrared emission cameras that identified tracking markers placed on the lower limbs. Reference positions were used, and the patients walked along a rubberized walkway. The Gait Profile Score (GPS) and Movement Analysis Profile (MAP) were used to analyze variables. Results were subjected to a Student’s t-test at 95% confidence interval. The R Core Team (2016) software was used for statistical analysis, graphically comparing the study results with data from healthy patients. Results: When comparing the kinematic data bilaterally, no statistical differences were found. However, graphical analysis showed changes in the gait of patients with CSM compared to healthy individuals. There were differences in all movements, with a more significant discrepancy in hip and knee flexion and extension, dorsiflexion and plantar flexion, and internal and external hip rotation. Conclusion: We describe a protocol for gait kinematics assessment using GPS and MAP, and we presented the differences in gait kinematics in patients with CSM compared to healthy individuals. Level of Evidence II, Prospective study.